Page last updated: 2024-11-12

neosolaniol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

neosolaniol: RN given refers to (3 alpha,4 beta,8 alpha)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID13818790
MeSH IDM0065720

Synonyms (2)

Synonym
neosolaniol
[(1s,2r,4s,7r,9r,10r,11s,12r)-11-acetyloxy-4,10-dihydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-2-yl]methyl acetate

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Several acute and chronic toxic effects were observed in humans after consumption of contaminated food."( Metabolism and cytotoxic effects of T-2 toxin and its metabolites on human cells in primary culture.
Gekle, M; Humpf, HU; Königs, M; Mulac, D; Schwerdt, G, 2009
)
0.35
"T-2 toxin, one of the most toxic mycotoxins, is commonly presented along with its metabolites, HT-2 toxin, neosolaniol (NEO), T-2 triol, and T-2 tetraol in foodstuff and feed."( Individual and combined cytotoxic effects of T-2 toxin and its four metabolites on porcine Leydig cells.
Guo, W; Ling, A; Sun, L; Sun, S; Yang, J; Zhao, Z, 2020
)
0.77

Dosage Studied

ExcerptRelevanceReference
" Both toxins caused statistically significant decreases in erythrocyte counts and increased the proportion of larger platelets compared to controls when dosed at 1 mg/kg body weight three times/wk for up to 5 wk."( Short-term effects of two fusarium toxins, diacetoxyscirpenol and neosolaniol monoacetate, in male Wistar rats.
Janse van Rensburg, DF; Jaskiewicz, K; Thiel, PG, 1987
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (11.54)18.7374
1990's4 (15.38)18.2507
2000's2 (7.69)29.6817
2010's11 (42.31)24.3611
2020's6 (23.08)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.36 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index5.12 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.57%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (96.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]